Jennifer Herz, GAICD, co-founded Biointelect and Biocelect to provide end to end strategic commercialisation services to the biopharmaceutical sector. Jennifer has over thirty years commercialisation experience and has held a variety of roles with responsibility for Australia, New Zealand and European markets. She was the first Managing Director of Sanofi Pasteur which was a start-up company and grew significantly to be an established major provider of vaccines in Australia, New Zealand and the Pacific Region.

During her time leading Biointelect she has overseen more than 650 projects providing rich and diverse experience in the complexity of life science product development and integrated commercial strategy. This experience includes successful FDA, EMA and TGA approvals and global launches as well as product and company failures, which is where the most learning is gained.

Jennifer is a Director of two NASDAQ listed US based biotech company’s Australian subsidiaries and has over twenty years Board experience across publicly listed, private and not-for-profit sectors. Past appointments include membership of NHMRC’s Health Research Impact Committee and the NSW Innovation and Productivity Council Jennifer is also a steering committee member of the Australian AMR Network (AAMRNet)

She has previously served on the Board of Medicines Australia as Director and Vice Chair. She was also active in a variety of European and International Industry Association working groups responsible for liaison with health authorities including European Institutions and the WHO.